Comments

Protara Therapeutics

TARANASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.39
0.073.02%
At Close: -
$2.22
-0.17-7.11%
After Hours: Jul 17, 6:53 PM EDT
15 minutes delayed
Protara Therapeutics (TARA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$30.00
Lowest Price Target1
$22.00
Consensus Price Target1
$25.00

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Protara Therapeutics (NASDAQ:TARA) Stock, Analyst Ratings, Price Targets, Forecasts

Protara Therapeutics Inc has a consensus price target of $25 based on the ratings of 3 analysts. The high is $30 issued by Oppenheimer on April 22, 2024. The low is $22 issued by Guggenheim on July 10, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co. on May 6, 2024, April 22, 2024, and April 8, 2024, respectively. With an average price target of $25.33 between HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co., there's an implied 1041.14% upside for Protara Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Apr
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Protara Therapeutics

Buy NowGet Alert
05/06/2024Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23ReiteratesBuy → BuyGet Alert
04/22/2024Buy Now1251.35%Oppenheimer
Leland Gershell
$26 → $30MaintainsOutperformGet Alert
04/08/2024Buy Now936.04%HC Wainwright & Co.
Andrew Fein
$23 → $23MaintainsBuyGet Alert
03/14/2024Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23ReiteratesBuy → BuyGet Alert
08/04/2023Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23ReiteratesBuy → BuyGet Alert
07/10/2023Buy Now890.99%Guggenheim
Charles Zhu
 → $22Assumes → BuyGet Alert
05/08/2023Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23Reiterates → BuyGet Alert
05/01/2023Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23Reiterates → BuyGet Alert
03/09/2023Buy Now936.04%HC Wainwright & Co.
Andrew Fein
 → $23Reiterates → BuyGet Alert
08/10/2022Buy Now936.04%HC Wainwright & Co.
Andrew Fein
$30 → $23MaintainsBuyGet Alert
05/09/2022Buy Now1251.35%HC Wainwright & Co.
Andrew Fein
$40 → $30MaintainsBuyGet Alert
11/08/2021Buy Now1431.53%Oppenheimer
Leland Gershell
—MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Protara Therapeutics (TARA) stock?

A

The latest price target for Protara Therapeutics (NASDAQ:TARA) was reported by HC Wainwright & Co. on May 6, 2024. The analyst firm set a price target for $23.00 expecting TARA to rise to within 12 months (a possible 936.04% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Protara Therapeutics (TARA)?

A

The latest analyst rating for Protara Therapeutics (NASDAQ:TARA) was provided by HC Wainwright & Co., and Protara Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Protara Therapeutics (TARA)?

A

There is no last upgrade for Protara Therapeutics

Q

When was the last downgrade for Protara Therapeutics (TARA)?

A

There is no last downgrade for Protara Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Protara Therapeutics (TARA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Protara Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Protara Therapeutics was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.

Q

Is the Analyst Rating Protara Therapeutics (TARA) correct?

A

While ratings are subjective and will change, the latest Protara Therapeutics (TARA) rating was a reiterated with a price target of $23.00 to $23.00. The current price Protara Therapeutics (TARA) is trading at is $2.22, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch